Endologix Inc (ELGX) - Financial and Strategic SWOT Analysis Review

Endologix Inc (ELGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive devices in treatment of aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA products are built on traditional minimally-invasive endovascular repair (EVAR) platform or endovascular sealing (EVAS) platform and Ovation system. The company’s EVAR products include AFX endovascular AAA system. Its Ovation system consists of a low-permeability polytetrafluoroethylene and a radiopaque nitinol suprarenal stent with integral anchors.

Endologix Inc Key Recent Developments

May 02,2019: Endologix reports first quarter 2019 financial results
Feb 25,2019: Endologix announces fourth quarter and fiscal year 2018 financial results
Jan 10,2019: Endologix names John D. Zehren as Chief Commercial Officer
Jan 07,2019: Endologix Announces Fourth Quarter and Full-Year 2018 Preliminary Financial Results and Provides 2019 Financial Guidance
Nov 15,2018: Endologix honors innovators of aortic therapy at VEITHsymposium

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company





Section 1 - About the Company
Endologix Inc - Key Facts
Endologix Inc - Key Employees
Endologix Inc - Key Employee Biographies
Endologix Inc - Major Products and Services
Endologix Inc - History
Endologix Inc - Company Statement
Endologix Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Endologix Inc - Business Description
R&D Overview
Endologix Inc - Corporate Strategy
Endologix Inc - SWOT Analysis
SWOT Analysis - Overview
Endologix Inc - Strengths
Endologix Inc - Weaknesses
Endologix Inc - Opportunities
Endologix Inc - Threats
Endologix Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Endologix Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Endologix Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Endologix Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 02, 2019: Endologix reports first quarter 2019 financial results
Feb 25, 2019: Endologix announces fourth quarter and fiscal year 2018 financial results
Jan 10, 2019: Endologix names John D. Zehren as Chief Commercial Officer
Jan 07, 2019: Endologix Announces Fourth Quarter and Full-Year 2018 Preliminary Financial Results and Provides 2019 Financial Guidance
Nov 15, 2018: Endologix honors innovators of aortic therapy at VEITHsymposium
Nov 01, 2018: Endologix reports third quarter 2018 financial results
Oct 02, 2018: Endologix Announces Third Quarter Preliminary Revenue Results and Raises Low End of 2018 Revenue Guidance Range
Aug 15, 2018: Endologix appoints Jeffrey S. Brown as Chief Operations Officer
Aug 09, 2018: Endologix reports second quarter 2018 financial results
Jun 25, 2018: Endologix Names Jeffry Fecho As Chief Quality Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer


List Of Tables


Endologix Inc, Key Facts
Endologix Inc, Key Employees
Endologix Inc, Key Employee Biographies
Endologix Inc, Major Products and Services
Endologix Inc, History
Endologix Inc, Subsidiaries
Endologix Inc, Key Competitors
Endologix Inc, Ratios based on current share price
Endologix Inc, Annual Ratios
Endologix Inc, Annual Ratios (Cont...1)
Endologix Inc, Interim Ratios
Endologix Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Endologix Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Endologix Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios


List Of Figures


Endologix Inc, Performance Chart (2014 - 2018)
Endologix Inc, Ratio Charts
Endologix Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Endologix Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019


Endologix Inc (ELGX) - Product Pipeline Analysis, 2019 Update

Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive devices in treatment of aortic diseases. The company lays focus on its

USD 750 View Report

Endologix Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Endologix Inc Company Profile is a detailed strategic and analytical report on Endologix Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Endologix Inc (ELGX) - Product Pipeline Analysis, 2019 Update

Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive devices in treatment of aortic diseases. The company lays focus on its

USD 750 View Report

Endologix Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Endologix Inc Company Profile is a detailed strategic and analytical report on Endologix Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available